Ndumele CE, et al
Lilly has not indicated plans to increase it
Introduction Retatrutide's 28.328.7% weight loss across two Phase 3 trials represents a breakthrough in obesity treatment but this exceptional efficacy comes with a side effect profile that's important to understand
JAMA 295(15):18241830 Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y, Peng P, Zhao G, Deng Y (2019) DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
10.1038/cddis.2012.83 55 DenicolaG
While there is no known direct drug interaction that makes the combination toxic, the digestive slowing caused by tirzepatide could theoretically interfere with how quickly the antiviral reaches therapeutic levels in your blood